...
首页> 外文期刊>Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society >Second try: Who returns for additional assisted reproductive technology treatment and the effect of a prior assisted reproductive technology birth
【24h】

Second try: Who returns for additional assisted reproductive technology treatment and the effect of a prior assisted reproductive technology birth

机译:第二次尝试:谁返回接受其他辅助生殖技术治疗以及先前辅助生殖技术诞生的影响

获取原文
获取原文并翻译 | 示例

摘要

Objective To evaluate the effect of a prior assisted reproductive technology (ART) live birth on subsequent live-birth rates. Design Historical cohort study. Setting Clinic-based data. Patient(s) The study population included 297,635 women with 549,278 cycles from 2004 to 2010 from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System. Try 1 refers to ART cycles up to and including the first live birth, try 2 to ART cycles after a first live birth. Intervention(s) None. Main Outcome Measure(s) Live-birth rates by cycle number, try number, and oocyte source. Result(s) Younger women at try 1 are more likely to return for try 2. Women returning for try 2 were more likely to have had an ART singleton versus multiple birth (33.2% after a try 1 singleton versus 8.1% after twins and 4.9% after triplets) and were less likely to have a diagnosis of diminished ovarian reserve or tubal factors. Live-birth rates were significantly higher for try 2 compared with try 1 for autologous fresh cycles, averaging 7.7 percentage points higher over five cycles. Live-birth rates were not significantly different for try 2 versus try 1 with thawed autologous cycles or either fresh or thawed donor cycles. Conclusion(s) These results indicate that when fresh autologous oocytes can be used, live-birth rates per cycle are significantly greater after a prior history of an ART live birth.
机译:目的评估先有辅助生殖技术(ART)活产对随后活产率的影响。设计历史队列研究。设置基于诊所的数据。患者从2004年至2010年,来自辅助生殖技术诊所结果报告系统的297,635名妇女共549,278个周期。尝试1指直到并包括首次活产的ART周期,尝试2指第一次活产后的ART周期。干预措施无。主要结果指标按周期数,尝试数和卵母细胞来源的存活率。结果尝试1的年轻女性更有可能再次尝试2。尝试2的女性更有可能接受ART单胎,而多胎分娩(尝试1单身后为33.2%,双胞胎为4.9%,双胞胎为4.9)三联体后的百分比),诊断为卵巢储备或输卵管因素减少的可能性较小。尝试2的活产率明显高于尝试1的自体新鲜周期,在五个周期中平均高7.7个百分点。尝试2与尝试1自体周期解冻或新鲜或解冻供体周期的活产率无明显差异。结论这些结果表明,当可以使用新鲜的自体卵母细胞时,在先前有ART活产史后,每个周期的活产率显着更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号